<DOC>
	<DOCNO>NCT01200277</DOCNO>
	<brief_summary>The standard care patient painful osteoporotic vertebral compression fracture ( VCF ) conservative therapy . Percutaneous vertebroplasty ( PV ) , new minimally invasive technique pain treatment bone cement inject fractured vertebra . Recent RCTs provide conflict result : two sham-controlled study show benefit PV unmask control RCT find significantly good pain relief PV acceptable cost .</brief_summary>
	<brief_title>A Trial Vertebroplasty Painful Acute Osteoporotic Vertebral Fractures</brief_title>
	<detailed_description>Objectives To evaluate efficacy bone cement injection PV patient acute painful osteoporotic compression fracture , compare simulate placebo procedure without injection bone cement . We hypothesize patient undergone PV would report less pain 1 day , 1 week 1 , 3 , 6 12 month ( primary outcome ) sham control group . Study design VERTOS IV multicenter RCT concern treatment patient painful osteoporotic VCF . Patients recruit Radiology department participate hospital randomize PV simulated procedure . Upon obtain informed consent independent central telephone operator complete randomisation procedure , use computer program . The maximum allow unbalance ( block size ) six , maximum sample size 84 participate centre . A total 180 patient enrol , 90 group . This base assumption 1.5 point difference pain relief ( VAS Score ) 20 % withdrawal rate ( α=0.05 β=0.20 , 7 measurement point ) . The enrolment patient take place four centre The Netherlands : St. Elisabeth Ziekenhuis Tilburg , Catharina Ziekenhuis Eindhoven , Medisch Spectrum Twente Enschede Albert Schweitzer Ziekenhuis Dordrecht . Randomization start January 2011 expect completion enrolment January 2013 . There one-year follow-up , possibility extend follow-up two year . The overall Institutional Review Board approval obtain St. Elisabeth Hospital Tilburg . In addition , participate centre obtain local Institutional Review Board Approval . This study register ClinicalTrials.gov. , NCT01200277 . Osteoporosis- pain medication All patient receive osteoporosis medication , bisphosphonates together supplemental calcium vitamin D. Pain medication demand patient record . Analgesics classify follow WHO classification : ( 1 ) Paracetamol ( acetaminophen ) , ( 2 ) Tramadol , ( 3 ) Tramadol Paracetamol , ( 4 ) Morphine . Non Steroid Anti Inflammatory Drugs ( NSAID ) prescribe patient intolerant opiate-derivatives already use . Corrections dose classification pain medication make necessary . Clinical follow-up An experienced nurse-practitioner request patient fill standard questionnaire 1 day , 1 week , 1 , 3 , 6 12 month procedure . The questionnaire consist VAS score question use pain medication , pain location , pain type . The VAS score pain score range 0 ( pain ) 10 ( bad pain ever . Other medical treatment visit alternative medical specialist , GP 's physical therapist record compare group . Secondary outcome back pain related disability QOL measure Roland Morris Disability ( RMD ) Questionnaire Questionnaire European Foundation Osteoporosis ( Qualeffo ) , respectively . The Qualeffo develop specifically patient osteoporosis . This questionnaire consist 41 question : pain , physical function , social function , general health perception , mental function . The Qualeffo score range 0 ( best quality life ) 100 ( bad quality life ) . This questionnaire complete five measurement moment ( 1 , 3 , 6 , 12 month procedure ) . The RMD questionnaire disability questionnaire measure functional status patient back pain . The RMD complete measurement point . All patient visit internist 1,3,6 12 month follow-up . All patient receive pain diary . Patients ask fill VAS score use analgesic record daily basis first month randomization . Sample size consideration Assuming 1.5 point difference pain relief measure VAS score withdrawal rate 20 % ( α=0.05 β=0.20 , 7 measurement point ) , total 180 patient enrol , 90 group . Statistical analysis The data analyse accord intention-to-treat principle . Standard statistical technique use describe characteristic patient group . We compare baseline characteristic two treatment group incomparability appear , secondary analysis adjust difference . The primary outcome , significant pain relief compare analysis variance repeat measure . If adjustment possible baseline incomparability need , analysis covariance do . Since expect difference two group particularly become evident 3 , 6 12 month , analysis also perform time point .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>VCF Xray spine ( minimal 15 % loss height ) level VCF Th5 low back pain ≤ 6 week time Xray ≥ 50 year age bone edema MRI fracture vertebral body focal tenderness VCF level decrease bone density Tscores ≤ 1 severe cardiopulmonary condition untreatable coagulopathy systemic local infection spine ( osteomyelitis , spondylodiscitis ) suspect alternative underlying disease ( malignancy ) radicular and/or cauda compression syndrome contraindication MRI</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>vertebral fracture</keyword>
	<keyword>vertebroplasty</keyword>
	<keyword>percutaneous</keyword>
</DOC>